Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  • 1, 2, 3, 4Email author,
  • 1, 2, 5,
  • 6, 7, 8,
  • 9,
  • 4, 10,
  • 1, 2, 10,
  • 1,
  • 6,
  • 6,
  • 9,
  • 9, 11,
  • 12,
  • 13,
  • 9 and
  • 1, 2, 3
BMC Medicine201917:35

https://doi.org/10.1186/s12916-019-1280-2

  • Received: 4 February 2019
  • Accepted: 4 February 2019
  • Published:

The original article was published in BMC Medicine 2019 17:18

Correction to: BMC Med

https://doi.org/10.1186/s12916-019-1257-1

The original article [1] contained two minor errors:
  1. 1)

    Author, Chee H. Ng’s middle initial was omitted;

     
  2. 2)

    The Competing Interests declaration omitted some information regarding author, Chee H. Ng.

     

These two errors have since been corrected.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, P.O. Box 291, Geelong, VIC, Australia
(2)
Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Level 1 North, Main Block, Parkville, VIC, Australia
(3)
Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, 30 Royal Parade, Parkville, VIC, Australia
(4)
Orygen, The National Centre of Excellence in Youth Mental Health, 35 Poplar Rd, Parkville, VIC, Australia
(5)
School of Medicine and Public Health, Faculty of Health and Medicine, the University of Newcastle, Callaghan, NSW, Australia
(6)
CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia
(7)
Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St Leonards, NSW, Australia
(8)
ARCHI, Sydney Medical School Northern, University of Sydney, Sydney, NSW, Australia
(9)
Department of Psychiatry, University of Melbourne, the Melbourne Clinic, 130 Church St Richmond, Melbourne, VIC, Australia
(10)
Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Rd, Parkville, VIC, Australia
(11)
NICM, School of Health and Science, Western Sydney University, Campbelltown, NSW, Australia
(12)
School of Psychology, University of Central Lancashire, Preston, UK
(13)
Melbourne Health, 300 Grattan St, Melbourne, VIC, Australia

Reference

  1. Berk M, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med. 2019;17:18 https://doi.org/10.1186/s12916-019-1257-1.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement